Hyundai Motor Group’s electric vehicle (EV) models IONIQ 5, Kia EV6, and the Genesis GV60 and G80, were given the highest Top Safety Pick+ grade in the collision tests conducted by the Insurance Institute for Highway Safety (IIHS)
The EVs were built on the carmaker’s dedicated EV platform dubbed E-GMP
Vehicles must receive the highest rating, "good," in each of the six collision safety categories, namely, driver-side small overlap front, passenger-side small overlap front, moderate overlap front, side collision, roof strength, and head restraints and seats, in order to receive the Top Safety Pick+ designation.
The front collision prevention system test grade must be greater than "advanced," and the headlight test grade must be higher than "acceptable."
Hyundai said that 15 vehicles, including those with internal combustion engines, had received Top Safety Pick+ ratings.


Why a ‘rip-off’ degree might be worth the money after all – research study
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance
Asian Currencies Trade Flat as Dollar Weakens in Thin New Year Trading
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas
Toyota Recalls 162,000 Tundra Vehicles in U.S. Over Multimedia Display Issue
South Korea Inflation Rises to 2.3% in December, Matching Market Expectations
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year
U.S. Dollar Starts 2026 Weak as Yen, Euro and Sterling Hold Firm Amid Rate Cut Expectations
Canada’s local food system faces major roadblocks without urgent policy changes
Asia Manufacturing PMI Rebounds as Exports and Tech Demand Drive Growth into 2026
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model
USDA $12 Billion Farm Aid Program Draws Mixed Reactions from Row Crop Farmers
The Beauty Beneath the Expressway: A Journey from Self to Service
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 



